TearSolutions, Inc.   Report issue

For profit Phase 2
Founded: Charlottesville VA United States (2013)
Status: No NME R&D (2013)

Organization Overview

First Clinical Trial
2017
NCT03226444
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

TearSolutions, Inc.